Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-01-06 @ 9:02 PM
Study NCT ID:
NCT04504734
Status:
TERMINATED
Last Update Posted:
2023-07-07
First Post:
2020-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bucillamine in Treatment of Patients With COVID-19
Sponsor:
Revive Therapeutics, Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RT-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None